Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
5.21
+0.72 (16.16%)
Sep 11, 2025, 11:09 AM - Market open
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $2.92 million as of September 11, 2025. Its market cap has decreased by -75.07% in one year.
Market Cap
2.92M
Enterprise Value
5.82M
1-Year Change
-75.07%
Ranking
Category
Stock Price
5.21
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $2.92M, a decrease of -98.03%. That is a compound annual growth rate of -58.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 2.52M | -21.92% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
| Apr 7, 2021 | 148.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |